线粒体载体SLC25A3作为NAFLD中氧化应激调节器的含义

Takeo Nakanishi1, Yuki Kawasaki2, Yoshinobu Nakamura1

  • 1Laboratory for Membrane Transport and Biopharmaceutics, Faculty of Pharmacy, Takasaki University of Health and Welfare, Takasaki, 370-0033, Japan.

PubMed
概括

在非酒精性脂肪性肝病 (NAFLD) 中,线粒体铜载体SLC25A3的减少表达增加了氧化应激,并可能促进NASH的进展. 这表明SLC25A3是NAFLD的新风险因素.